Temasek Holdings’s Vaxcyte PCVX Stock Holding History

Temasek Holdings’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,272	Closed	-$655K	–	76
2022 Q3	$655K	Hold	27,272	–	–	﹤0.01%	80
2022 Q2	$593K	Hold	27,272	–	–	﹤0.01%	95
2022 Q1	$659K	Hold	27,272	–	–	﹤0.01%	94
2021 Q4	$649K	Hold	27,272	–	–	﹤0.01%	91
2021 Q3	$692K	Buy	+27,272	New	+$661K	﹤0.01%	87
2021 Q2	–	Sell	-27,272	Closed	-$539K	–	104
2021 Q1	$539K	Buy	+27,272	New	+$686K	﹤0.01%	69

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Temasek Holdings's PCVX Position: Q4 2022 in Review

Temasek Holdings sold out of Vaxcyte (PCVX) in Q4 2022, closing a stake of 27,272 shares — an estimated $655K sold.

Temasek Holdings first reported a position in PCVX in Q1 2021 and held it in 6 quarters. The position peaked at $692K in Q3 2021. 198 funds tracked by Wall St. Rank hold PCVX as of Q4 2022.

Temasek Holdings reported no remaining Vaxcyte position as of Q4 2022 after selling out during the quarter.
Temasek Holdings sold 27,272 Vaxcyte shares in Q4 2022, an estimated $655K.
Temasek Holdings first reported a position in Vaxcyte in Q1 2021 and held it in 6 quarters.
Temasek Holdings's Vaxcyte position peaked at $692K in Q3 2021.
198 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2022.

Based on Temasek Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.